Logo image of HBT

HBT FINANCIAL INC/DE (HBT) Stock Fundamental Analysis

NASDAQ:HBT - Nasdaq - US4041111067 - Common Stock - Currency: USD

26.35  +1.04 (+4.11%)

After market: 26.35 0 (0%)

Fundamental Rating

4

Taking everything into account, HBT scores 4 out of 10 in our fundamental rating. HBT was compared to 396 industry peers in the Banks industry. HBT has a medium profitability rating, but doesn't score so well on its financial health evaluation. HBT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year HBT was profitable.
HBT had a positive operating cash flow in the past year.
HBT had positive earnings in each of the past 5 years.
HBT had a positive operating cash flow in each of the past 5 years.
HBT Yearly Net Income VS EBIT VS OCF VS FCFHBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

HBT's Return On Assets of 1.47% is amongst the best of the industry. HBT outperforms 88.89% of its industry peers.
HBT has a better Return On Equity (13.27%) than 87.37% of its industry peers.
Industry RankSector Rank
ROA 1.47%
ROE 13.27%
ROIC N/A
ROA(3y)1.35%
ROA(5y)1.27%
ROE(3y)13.93%
ROE(5y)13.11%
ROIC(3y)N/A
ROIC(5y)N/A
HBT Yearly ROA, ROE, ROICHBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of HBT (32.59%) is better than 88.13% of its industry peers.
In the last couple of years the Profit Margin of HBT has declined.
HBT does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 32.59%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-3.04%
PM growth 5Y-4.7%
GM growth 3YN/A
GM growth 5YN/A
HBT Yearly Profit, Operating, Gross MarginsHBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

HBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
HBT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for HBT has been increased compared to 5 years ago.
Compared to 1 year ago, HBT has an improved debt to assets ratio.
HBT Yearly Shares OutstandingHBT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
HBT Yearly Total Debt VS Total AssetsHBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

The Debt to FCF ratio of HBT is 1.10, which is an excellent value as it means it would take HBT, only 1.10 years of fcf income to pay off all of its debts.
HBT has a better Debt to FCF ratio (1.10) than 71.21% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that HBT is not too dependend on debt financing.
HBT's Debt to Equity ratio of 0.17 is in line compared to the rest of the industry. HBT outperforms 50.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.1
Altman-Z N/A
ROIC/WACCN/A
WACC12.69%
HBT Yearly LT Debt VS Equity VS FCFHBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HBT Yearly Current Assets VS Current LiabilitesHBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.27% over the past year.
The Earnings Per Share has been decreasing by -7.46% on average over the past years.
Looking at the last year, HBT shows a decrease in Revenue. The Revenue has decreased by -1.19% in the last year.
Measured over the past years, HBT shows a small growth in Revenue. The Revenue has been growing by 6.49% on average per year.
EPS 1Y (TTM)4.27%
EPS 3Y5.17%
EPS 5Y-7.46%
EPS Q2Q%10.53%
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y12.01%
Revenue growth 5Y6.49%
Sales Q2Q%3.82%

3.2 Future

The Earnings Per Share is expected to grow by 1.55% on average over the next years.
Based on estimates for the next years, HBT will show a small growth in Revenue. The Revenue will grow by 3.84% on average per year.
EPS Next Y3.89%
EPS Next 2Y1.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.94%
Revenue Next 2Y3.84%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HBT Yearly Revenue VS EstimatesHBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
HBT Yearly EPS VS EstimatesHBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5

4. Valuation

4.1 Price/Earnings Ratio

HBT is valuated reasonably with a Price/Earnings ratio of 10.80.
74.24% of the companies in the same industry are more expensive than HBT, based on the Price/Earnings ratio.
HBT is valuated cheaply when we compare the Price/Earnings ratio to 27.46, which is the current average of the S&P500 Index.
HBT is valuated reasonably with a Price/Forward Earnings ratio of 10.87.
HBT's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, HBT is valued rather cheaply.
Industry RankSector Rank
PE 10.8
Fwd PE 10.87
HBT Price Earnings VS Forward Price EarningsHBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

68.18% of the companies in the same industry are more expensive than HBT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.6
EV/EBITDA N/A
HBT Per share dataHBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.78
PEG (5Y)N/A
EPS Next 2Y1.55%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.32%, HBT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.29, HBT pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.34, HBT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.32%

5.2 History

HBT has been paying a dividend for over 5 years, so it has already some track record.
HBT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years4
HBT Yearly Dividends per shareHBT Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

32.80% of the earnings are spent on dividend by HBT. This is a low number and sustainable payout ratio.
DP32.8%
EPS Next 2Y1.55%
EPS Next 3YN/A
HBT Yearly Income VS Free CF VS DividendHBT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HBT Dividend Payout.HBT Dividend Payout, showing the Payout Ratio.HBT Dividend Payout.PayoutRetained Earnings

HBT FINANCIAL INC/DE

NASDAQ:HBT (7/21/2025, 4:30:01 PM)

After market: 26.35 0 (0%)

26.35

+1.04 (+4.11%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-21 2025-07-21/bmo
Earnings (Next)10-20 2025-10-20/bmo
Inst Owners24.8%
Inst Owner Change-0.03%
Ins Owners5.2%
Ins Owner Change3.23%
Market Cap830.02M
Analysts75.56
Price Target26.32 (-0.11%)
Short Float %0.85%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield 3.32%
Yearly Dividend0.75
Dividend Growth(5Y)N/A
DP32.8%
Div Incr Years3
Div Non Decr Years4
Ex-Date05-06 2025-05-06 (0.21)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.53%
Min EPS beat(2)5.48%
Max EPS beat(2)9.58%
EPS beat(4)3
Avg EPS beat(4)3.71%
Min EPS beat(4)-1.77%
Max EPS beat(4)9.58%
EPS beat(8)5
Avg EPS beat(8)1.43%
EPS beat(12)9
Avg EPS beat(12)4.08%
EPS beat(16)13
Avg EPS beat(16)6.31%
Revenue beat(2)2
Avg Revenue beat(2)0.94%
Min Revenue beat(2)0.21%
Max Revenue beat(2)1.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-2.23%
Max Revenue beat(4)1.66%
Revenue beat(8)2
Avg Revenue beat(8)-3.16%
Revenue beat(12)4
Avg Revenue beat(12)-2.37%
Revenue beat(16)6
Avg Revenue beat(16)-1.85%
PT rev (1m)0%
PT rev (3m)0.39%
EPS NQ rev (1m)-0.47%
EPS NQ rev (3m)3.96%
EPS NY rev (1m)0%
EPS NY rev (3m)4.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.7%
Valuation
Industry RankSector Rank
PE 10.8
Fwd PE 10.87
P/S 3.61
P/FCF 9.6
P/OCF 9.02
P/B 1.47
P/tB 1.77
EV/EBITDA N/A
EPS(TTM)2.44
EY9.26%
EPS(NY)2.42
Fwd EY9.2%
FCF(TTM)2.75
FCFY10.42%
OCF(TTM)2.92
OCFY11.08%
SpS7.31
BVpS17.94
TBVpS14.89
PEG (NY)2.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 13.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 32.59%
GM N/A
FCFM 37.59%
ROA(3y)1.35%
ROA(5y)1.27%
ROE(3y)13.93%
ROE(5y)13.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-3.04%
PM growth 5Y-4.7%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 1.1
Debt/EBITDA N/A
Cap/Depr 94.93%
Cap/Sales 2.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 115.33%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score9
WACC12.69%
ROIC/WACCN/A
Cap/Depr(3y)58.78%
Cap/Depr(5y)49.19%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.26%
Profit Quality(3y)112.69%
Profit Quality(5y)98.53%
High Growth Momentum
Growth
EPS 1Y (TTM)4.27%
EPS 3Y5.17%
EPS 5Y-7.46%
EPS Q2Q%10.53%
EPS Next Y3.89%
EPS Next 2Y1.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.19%
Revenue growth 3Y12.01%
Revenue growth 5Y6.49%
Sales Q2Q%3.82%
Revenue Next Year4.94%
Revenue Next 2Y3.84%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.05%
FCF growth 3Y25.75%
FCF growth 5Y-0.82%
OCF growth 1Y26.3%
OCF growth 3Y27.42%
OCF growth 5Y-0.02%